Effectiveness of e-Health Interventions on Increasing Uptake of Human Papillomavirus (HPV) Vaccination and Cervical Cancer Screening (CCS) in Women: A Systematic Review and Meta-Analysis

Effectiveness of e-Health Interventions on Increasing Uptake of Human Papillomavirus (HPV) Vaccination and Cervical Cancer Screening (CCS) in Women: A Systematic Review and Meta-Analysis

Bachelor's

Saved in:

Bibliographic Details
Main Author:	TAN SHU TENG, PAMELA
Other Authors:	NURSING/ALICE LEE CTR FOR NURSING STUD
Format:	Theses and Dissertations
Published:	2021
Subjects:	Cervical cancer prevention Cervical cancer screening e-Health Human papillomavirus (HPV) vaccination
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/194143
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination
by: Pitts, M., et al.
Published: (2011)

From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness
by: Jit, Mark, et al.
Published: (2022)

Singaporean women's knowledge of human papillomavirus (HPV) and attitudes toward HPV vaccination
by: Pitts, M., et al.
Published: (2011)

Human Papillomavirus (HPV) and Cervical Cancer
by: Biswas, A.
Published: (2013)

Intention to pay for hpv vaccination among women of childbearing age in vietnam
by: Le, X.T.T., et al.
Published: (2021)

Cervical cancer screening and vaccination: understanding the latest guidelines.
by: Lim, Tessa Si Chi, et al.
Published: (2022)

THE STUDY OF A NOVEL MIXED LINEAGE LEUKEMIA 5 ISOFORM AND ITS ASSOCIATION WITH HUMAN PAPILLOMAVIRUS 16/18 - RELATED HUMAN CERVICAL CANCERS
by: YEW CHOW WENN
Published: (2013)

The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach
by: Phetsavanh Chanthavilay, et al.
Published: (2017)

Cervical dysplasia: Assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy
by: Lim, E.H., et al.
Published: (2014)

Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
by: Phua, LC, et al.
Published: (2021)

Cost-effectiveness of different human papillomavirus vaccines in Singapore
by: Lee, V.J., et al.
Published: (2014)

High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis
by: Yeo-Teh N.S.L., et al.
Published: (2019)

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.
by: Castellsagué, X, et al.
Published: (2015)

Prevalence of human papillomavirus types 16 and 18 in cervical carcinomas: A study by dot and southern blot hybridization and the polymerase chain reaction
by: Low, S.-H., et al.
Published: (2014)

What works for human papillomavirus vaccine introduction in low and middle-income countries?
by: Howard, N, et al.
Published: (2021)

THE SENSITIVITY & SPECIFICITY OF TRUSCAN VERSUS PAP SMEAR IN SCREENING FOR CERVICAL EPITHELIAL ABNORMALITIES AND CANCER PRECURSORS
by: FONG KAH LENG
Published: (2011)

Health care provider's experience and perspective of cervical cancer screening in Singapore: A qualitative study
by: Chua, BWB, et al.
Published: (2022)

What is New about Cervical Cancer during Last Decade?
by: Chuenkamon Charakorn, et al.
Published: (2022)

Casual relationship between health promoting behavior and quality of life in cervical cancer patients undergoing radiotherapy
by: Pimsurang Taechaboonsermsak, et al.
Published: (2015)

IDENTIFYING CELLULAR TARGETS OF HIGH-RISK HPV ONCOGENES E6 AND E7
by: YEO SHU LING, NICOLE
Published: (2019)

Past, present, and future of HPV research: Highlights from the 19th International Papillomavirus Conference-HPV2001
by: Villa, L.L., et al.
Published: (2014)

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries
by: Howard, N, et al.
Published: (2021)

The pivotal role of the pathology laboratory in the context of a Singapore cervical cancer screening programme
by: Chang, A.R.
Published: (2012)

Socioeconomic factors affecting colorectal, breast and cervical cancer screening in an Asian urban low-income setting at baseline and post-intervention
by: Wee, L.E., et al.
Published: (2014)

The Results of High-dose Rate Intracavitary Brachytherapy for Uterine Cervical Carcinoma in Ramathibodi Hospital
by: Chuleeporn Jiarpinitnun, et al.
Published: (2022)

Barriers to and facilitators of cervical cancer screening among women in Southeast Asia: A systematic review
by: Chua, Brandon, et al.
Published: (2022)

The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- And middle-income countries
by: McCormack, M, et al.
Published: (2021)

Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients
by: Yap, E.H., et al.
Published: (2016)

Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients
by: Yap, E.H., et al.
Published: (2012)

Diagnostic sensitivity of polymerase chain reaction and Southern blot hybridization for the detection of human papillomavirus DNA in biopsy specimens from cervical lesions
by: Tham, K.M., et al.
Published: (2014)

Outcome of 6 fractions of 5.3 Gray HDR brachytherapy in combination with external beam radiotherapy for treatment of cervical cancer
by: Koh, W.Y., et al.
Published: (2016)

Promoting of cervical cancer screening behavior among women aged 30-60 years through women-peer leaders in Songphenong district, Suphanburi Province
by: Natthaporn Wetwisit, et al.
Published: (2021)

Electrochemical DNA-nano biosensor for the detection of cervical cancer-causing HPV-16 using ultrasmall Fe₃O₄-Au core-shell nanoparticles
by: Rasouli, Elisa, et al.
Published: (2023)

The roles of DNA(cytosine-5) methyltransferase1 in carcinogenesis related to cellular factors, virus and chemicals
by: VINAY BADAL
Published: (2010)

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016
by: Gallagher, KE, et al.
Published: (2021)

The role of immunotherapy in the treatment of advanced cervical cancer: Current status and future perspectives
by: Walsh, RJ, et al.
Published: (2021)

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries
by: Gallagher, KE, et al.
Published: (2021)

A study of the immunomodulatory characteristics of FIP-Fve protein and its adjuvant effects in tumor immunotherapy
by: DING YING
Published: (2010)

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies
by: Rosillon, Dominique, et al.
Published: (2021)

Molecular diagnosis of genital HPV DNA types by polymerase chain reaction and sensitivity-standardized filter in situ hybridization in randomly sampled cohorts of Singapore women
by: Chow, V., et al.
Published: (2014)